Displaying 13 - 24 of 39
Viral Hepatitis
5

GSK: “Looking to the future of hepatitis B: how can we achieve functional cure?” - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
5

GSK: "Investigating IBAT inhibition in itch – a new tool for an age-old problem?" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
5

GSK: "Investigating IBAT inhibition in itch – a new tool for an age-old problem?" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
7

GSK: "Practical tips towards providing holistic care to patients with PBC" - EASL Congress 2023

View
Viral Hepatitis
5

GSK: “Looking to the future of hepatitis B: how can we achieve functional cure?” - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
7

GSK: "Practical tips towards providing holistic care to patients with PBC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
7

GSK: "Practical tips towards providing holistic care to patients with PBC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
7

GSK: "Practical tips towards providing holistic care to patients with PBC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
7

GSK: "Practical tips towards providing holistic care to patients with PBC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
7

GSK: "Practical tips towards providing holistic care to patients with PBC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View
Immune-Mediated and Cholestatic Diseases
5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View
Displaying 13 - 24 of 39